Colorcon, a provider of pharmaceutical film coating systems, has signed an exclusive distribution arrangement with ASHA Cellulose to supply its polymer-based products in selected international regions.
Scheduled to begin on 15 May 2025, the long-term agreement spans Europe, the Middle East, Africa, as well as Northeast and Southeast Asia.
ASHA Cellulose president Raju Shah said: “Asha Cellulose has been involved in manufacturing ASHACEL Ethyl Cellulose and ASHAKOTE Aqueous Ethyl Cellulose dispersion using in-house capabilities and a world-class infrastructure.
“With this partnership, we are confident that the unique combination of our polymer expertise and Colorcon’s technical prowess and customer reach will help us serve our customers better.”
The ASHA Cellulose range features ASHACEL, a water-insoluble, organosoluble cellulose ether used in the health supplement and pharmaceutical sectors.
Its functions include taste masking, modified release, and acting as a film-forming and binding agent. It also supports various formulation requirements through its rheological properties.
The agreement also includes ASHAKOTE, a 30% water-based ethyl cellulose dispersion designed for extended release and moisture protection.
This product is suited to markets where organic solvents are limited or prohibited.
Colorcon will serve as the sole distributor for these products in the designated territories.
Colorcon Excipient Technologies vice-president Kurt Fegely said: “Colorcon is excited to announce our new partnership with ASHA Cellulose to further the support we provide to our customers in barrier membrane and multi-particulate development.
“ASHA has been a leader in the cellulosic polymer industry for more than 25 years. Our partnership combines an impressive product portfolio, recognised leadership in controlled release multiparticulate applications and regulatory excellence, helping our customers achieve success in drug delivery.”
Colorcon CEO Simon Tasker said: “This partnership is a great example of our commitment to the pharmaceutical and nutraceutical industries. We are excited to bring together our two organisations to provide an enhanced product portfolio, high-quality manufacturing and dedication to service excellence, supply reliability and technical expertise to our global customers.”
